Edgewell Personal Care Company EPC
27.82
0.49
1.79%
as of 25 Sep
- Market cap
- $1.3B
- P/E
- 0.0×
Follow EPC
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
39.15 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.43 | 0.36 | 0.44 | 0.55 | |
P/FCF ratio |
23.36 | 21.89 | 20.42 | 23.63 | |
P/Operating CF |
13.05 | (6.31) | 18.27 | 10.43 | |
P/B ratio |
0.62 | 0.53 | 0.69 | 0.85 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.97 | 0.95 | 0.88 | 0.94 | |
EV/EBITDA |
11.64 | 13.56 | 15.96 | 21.20 | |
EV/Operating CF |
18.23 | 19.67 | 16.80 | 17.49 | |
EV/FCF |
52.14 | 58.57 | 40.56 | 40.46 | |
Quick Ratio |
0.64 | 0.76 | 0.79 | 0.86 | |
Current Ratio |
1.76 | 2.12 | 1.81 | 1.84 | |
Net Debt/EBITDA |
70.16 | 540.63 | 25.19 | 19.45 | |
Debt/Assets |
36.83% | 40.36% | 35.22% | 35.22% | |
Debt/Equity |
0.89 | 1.02 | 0.86 | 0.85 | |
Asset Turnover |
0.59 | 0.60 | 0.61 | 0.61 | |
Operating CF/Net income |
(2.42) | 1.92 | (5.12) | 8.66 | |
Capex/Depreciation |
(1.19) | (0.54) | (0.73) | (0.84) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
2.37% | 3.26% | 2.87% | 2.33% | |
Selling, General and Administrative Expense of Revenue |
25.51% | 35.00% | 32.65% | 33.59% | |
Intangible Assets out of Total Assets |
0.52 | 0.52 | 0.55 | 0.55 | |
Share Based Compensation of Revenue |
0.78% | 0.80% | 1.08% | 1.00% | |
Graham Net Nets |
(1.25) | (1.54) | (0.98) | (0.78) | |
Graham Number |
19.56 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
2.55% | (4.99%) | (7.87%) | (7.45%) | |
Free Cash Flow Yield |
4.28% | 4.57% | 4.90% | 4.23% | |
Revenue per Share |
15.40 | 9.07 | 11.17 | 12.37 | |
Operating CF per Share |
1.56 | (2.70) | 1.17 | 2.57 | |
Capex per Share |
(0.58) | (0.25) | (0.30) | (0.34) | |
Free Cash Flow per Share |
0.98 | (2.95) | 0.87 | 2.24 | |
Cash per Share |
4.75 | 4.79 | 6.45 | 8.61 | |
Shareholders Equity per Share |
32.70 | 31.89 | 31.14 | 31.67 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
32.70 | 31.89 | 31.14 | 31.67 | |
Free Cash Flow |
46.50 | (137.50) | 40.30 | 103.10 | |
Working Capital |
430.00 | 559.60 | 495.70 | 508.40 | |
Capital Expenditures |
(27.60) | (11.60) | (14.00) | (15.60) | |
Net Current Asset Value |
(1,207.70) | (1,224.60) | (975.60) | (963.50) | |
EV/EBIT |
22.35 | 31.08 | 52.14 | 119.11 | |
Capex to Sales |
0.04 | 0.03 | 0.03 | 0.03 | |
Net Profit Margin |
(4.18%) | (15.54%) | (2.04%) | 2.40% | |
Price to Operating Income |
10.01 | 11.62 | 26.25 | 69.56 | |
| Other line items | |||||
Average Receivables |
123.60 | 137.25 | 181.80 | 136.30 | |
Average Payables |
219.50 | 208.45 | 223.35 | 227.60 | |
Average Inventory |
455.55 | 481.40 | 481.15 | 460.70 | |
Average Assets |
3,743.60 | 3,735.15 | 3,653.00 | 3,664.35 | |
Average Common Equity |
1,568.60 | 1,493.60 | 1,481.00 | 1,513.95 |
Columns are period end dates